Taiwan’s JHL Biotech Raises $45.6M In Series C Round
May 14, 2015 — 17:09 CST
This Data Is Locked!
This area is available only to Subscribers.
Taiwan-based bio-pharmaceutical firm JHL Biotech, Inc. has completed US$45.6 million series C round of financing led by an unnamed investor, ahead of the company’s planned... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
